Mandate

Nordic Capital – aquisition of Finnveden AB

March 29, 2005

Nordic Capital, the Swedish private equity firm, has succesfully completed the public offer to acquire all outstanding shares of Finnveden AB, the Swedish engineering company, for a consideration of SEK 2.0bn (USD 288.1m), and currently holds more than 99% of the total number of shares and votes in Finnveden AB.

Vinge acted for Nordic Capital.
Johan Cederlund (responsible partner)
Sara Mindus (associate)

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024